Stocktoria
DYADIC INTERNATIONAL INC DYAI
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2004-11-05
DYADIC INTERNATIONAL INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -232.8% | -168.8% | -283.9% | -346.9% | -612.7% | -625.9% | -552.2% | -586.1% | -939.7% |
| Net margin | -238.3% | -166.2% | -234.4% | -332.2% | -543.7% | -582.1% | -494.2% | -439.4% | -281.6% |
| Return on assets | -74.0% | -58.5% | -82.7% | -71.0% | -61.4% | -31.0% | -22.2% | -13.1% | -4.2% |
| Return on equity | -597.6% | -235.2% | -115.6% | -87.8% | -71.1% | -32.8% | -23.2% | -13.4% | -4.3% |
| Current ratio | 2.68 | 4.01 | 3.58 | 5.48 | 8.22 | 18.32 | 22.44 | 50.31 | 64.53 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.